2009
Prevalence and Predictors of Distress in Young Women with Newly Diagnosed Early Stage Breast Cancer.
Ruddy K, Gelber S, Tamimi R, Mayer E, Schapira L, Come S, Meyer M, Winer E, Partridge A. Prevalence and Predictors of Distress in Young Women with Newly Diagnosed Early Stage Breast Cancer. Cancer Research 2009, 69: 1067-1067. DOI: 10.1158/0008-5472.sabcs-09-1067.Peer-Reviewed Original ResearchStage breast cancerBreast cancerOverall distressYoung womenHADS scoresProspective multi-center cohort studyAdvanced-stage breast cancerMulti-center cohort studyEarly-stage breast cancerMultivariate logistic regression modelBaseline surveyOnly sociodemographic factorCentral pathology reviewEarly breast cancerMultivariate logistic regressionPercent of womenCourse of careMedical history itemsLogistic regression modelsBreast cancer diagnosisEligible womenCohort studyMedian agePathology reviewHospital Anxiety
2001
Liposomal anthracyclines for breast cancer
Sparano J, Winer E. Liposomal anthracyclines for breast cancer. Seminars In Oncology 2001, 28: 32-40. PMID: 11552228, DOI: 10.1016/s0093-7754(01)90197-6.Peer-Reviewed Original ResearchConceptsBreast cancerLiposomal anthracyclinesAdvanced-stage breast cancerStage breast cancerConventional anthracyclinesTLC DLiposomal daunorubicinCardiac toxicityConventional doxorubicinLiposomal doxorubicinPreclinical modelsAnthracyclinesCancer typesCytotoxic agentsNormal tissuesCancerFurther studiesChronic toxicityDoxorubicinTreatmentToxicityLiposomal doxorubicin preparationsAgentsCyclophosphamideVinorelbine